SavedAdd your journal

Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2019 / Cilt: 33 - Sayı: 2

The Results of Intravitreal Bevacizumab Injection by Macular Edema Associated with Retina Ven Obstruction

Retina Ven Tıkanıklığına Bağlı Gelişen Maküla Ödeminde İntravitreal Bevacizumab Enjeksiyonu Sonuçları

Yavuz ORUÇ
Berrak Şekeryapan GEDİZ
Pages
89–93
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The t-test was used to compare the data and P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate visual acuity and central foveal thickness changes after bevacizumab intravitreal injection in the treatment of macular edema due to retinal vein occlusion.
📊
Key Findings & Data:Materials and Methods: In this retrospective study, 21 eyes of 21 patients who underwent bevacizumab intravitreal injection with diagnosis of macular edema due to retinal vein occlusion were examined.
💡
Conclusion & Impact:The t-test was used to compare the data and P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate visual acuity and central foveal thickness changes after bevacizumab intravitreal injection in the treatment of macular edema due to retinal vein occlusion. Materials and Methods: In this retrospective study, 21 eyes of 21 patients who underwent bevacizumab intravitreal injection with diagnosis of macular edema due to retinal vein occlusion were examined. Three doses of intravitreal 1.25mg / 0.05ml bevacizumab injection was applied to the patients with one month intervals. Visual acuity (VA), central foveal thickness (CFT) and complications were recorded. The t-test was used to compare the data and P

Özet

Amaç: Retina ven tıkanıklığına bağlı oluşan maküla ödemi tedavisinde intravitreal bevacizumabenjeksiyonu sonrası görme keskinliği ve santral fovea kalınlığı değişikliklerini incelemek.Gereç ve Yöntem: Bu retrospektif çalışmaya retina ven tıkanıklığına bağlı maküla ödemi tanısıalarak takip edilen intravitreal bevacizumab enjeksiyonu uygulanan 21 hastanın 21 gözü incelendi.Olgulara birer ay aralıklarla izlenerek 3 doz intravitreal 1.25 mg/0.05 mL bevacizumab enjeksiyonuuygulandı. Görme keskinliği (GK), santral fovea kalınlıkları (SFK) ve komplikasyonlar kayıt edildi.Verilerin karşılaştırılmasında t-test kullanıldı, P

🔖

Cite This Article

ORUÇ, Y., GEDİZ, B. Ş. (2022). The Results of Intravitreal Bevacizumab Injection by Macular Edema Associated with Retina Ven Obstruction. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 33 - Sayı: 2, 89–93. https://ajindex.com/articles/514497

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Hayreh SS. Ocular vascular occlusive disorders: Natural history of visual out come. Retin Eye Res 2014; 41: 1-25.
  2. Sekiryu T, Iida T, Sakai E, et al. Fundus autofluorescence and optical coherence tomography findings in branch retinal vein occlusion. J Ophthalmol 2012; 2012: 638064. Sogawa K, Nagaoka T, Ishibazawa A, et al. En-face optical coherence tomography angiography of neovascularization elsewhere in hemicentral retinal vein occlusion. Int Med Case Rep J 2015; 8: 263-266.
  3. Klein R, Moss SE, Meuer SM, Klein BEK. The 15-year cumulative incidence of retinal vein occlusion: The Beaver Dam Eye Study. Arch Ophthalmol 2008; 126: 513-518.
  4. McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: An evidence-based systematic review. Ophthalmology 2007; 114: 835-854.
  5. Noma H, Minamoto A, Funatsu H, et al Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Arch Clin Exp Ophthalmol 2006; 244: 309-315.
  6. Arnarsson A, Stefánsson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 2000; 41: 877-879.
  7. Vogl WD, Waldstein SM, Gerendas BS, Schmidt-Erfurth U, Langs G. Predicting macular edema recurrence from spatio-temporal signatures in optical coherence tomography images. IEEE Trans Med Imaging 2017; 36: 1773-1783.
  8. Noh D, Ryu G, Lee J, Sagong M. Impact of early anatomical and functional responses to bevacizumab in macular edema secondary to branch retinal vein occlusion. Ophthalmologica 2018; 239: 194-204.
  9. Tsimberidou AM, Fu S, Ng C, et al. A phase 1 study of hepatic arterialinfusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. Cancer 2010; 116: 4086-4094.
  10. Azhar MN, Muzaffar W, Arain MA, Farooq O. Intravitreal bevacizumab (IVB) for macular edema secondary to branch retinal vein occlusion (BRVO). J Coll Physicians Surg Pak 2018; 28: 758-761.
  11. Larsson J, Bauer Andreasson S. The 30-Hz flicker cone ERG for monitoring theearly course of central retinal vein occlusion. Acta Ophthalmol Scand 2000; 78: 187-190. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24: 493-519. Anonim. Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984; 98: 271-282. Battaglia